|
|
$894 million deal ends pain of Pfizer's lawsuits
TRENTON, N.J. - Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits.
Nations:U.S. Activities:U.S. Painkiller Crisis Source:(AP)
2008-10-17
Study: Older brains don't benefit from painkillers
Results from a large government experiment are dimming hopes that two common painkillers can prevent Alzheimer's disease or slow mental decline in older people.
2008-05-13
Pfizer reaches deal with some Celebrex users: report
Pfizer Inc has reached tentative deals with some patients who claim to have suffered heart attacks and strokes from taking the company's Celebrex and Bextra pain medicines, the Wall Street Journal said on Friday, citing plaintiff attorneys.
Activities:U.S. Painkiller Crisis
2008-05-02
Celebrex risky in high-risk patients, study finds
Doctors should prescribe the lowest doses of Celebrex possible in patients at high risk of heart problems, researchers who did a combined analysis of six studies of the Pfizer Inc pain drug said on Monday.
2008-03-31
Celebrex disrupts heart rhythm in fruit flies
Celebrex, an arthritis drug in the same class as the recalled painkiller Vioxx, caused irregular heartbeats in fruit flies and in heart cells taken from laboratory rats, U.S. researchers said on Friday.
2008-01-25
|